Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate versus azathioprine in adults with severe chronic atopic dermatitis
2009-011132-34Phase 3Active
- Sponsor
- Academic Medical Center
- Start
- Jun 2009
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in atopic dermatitis (AD) comparing Methotrexate arm with Azathioprine arm (2 arms). Primary endpoints: SCORAD response at week 12 and Investigator's Global Assessment response at week 12. Started Jun 2009; status: active.
02
Drugs
methotrexateazathioprine
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2009-011132-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011132-34.